Loxigen, Inc.
Charleston, SC
- UEI
- NGP6JHL2LJW5
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2669 Doubletree Ct, Charleston, SC 29414, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Developing novel LOX inhibitors to target chemotherapy resistant tnbc | National Cancer Institute (NIH) | $4,442,364 |
Quick answers
Is Loxigen, Inc. registered in SAM.gov?
Yes. Loxigen, Inc.'s SAM.gov registration is active through July 27, 2027.
What is Loxigen, Inc.'s most recent federal award?
Loxigen, Inc.'s most recent federal grant award is Developing novel LOX inhibitors to target chemotherapy resistant tnbc (R42CA275622), from National Cancer Institute (NIH), on June 8, 2023.
On GovTribe
See Loxigen, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors